3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
18
NETWORK
3
INDUSTRY
3
OTHER_GOV
1
NIH
1
FED
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Conditions
Prostatic Neoplasms
7
Colorectal Neoplasms
6
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Ovarian Neoplasms
2
Leiomyoma
2
Endometrial Neoplasms
2
Colonic Polyps
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Adenoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Sezary Syndrome
1
Pseudotumor Cerebri
1
Proteinuria
1
Prostate cancer, familial
1
Patients With Prostate Cancer
1
Patient Preference
1
Patient Compliance
1
Papillomavirus Infections
1
Neoplasms
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lung Neoplasms
1
Healthy
1
Genital Neoplasms, Female
1
Interventions
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Observational
×
Dendritic Cell Sarcoma, Interdigitating
×
Clear all
NCT06452446
2025-02-10
Selinexor
Durham VA Medical Center
Active not recruiting
20 enrolled